Guanylate-binding protein 1 inhibits nuclear delivery of Kaposi's sarcomaassociated herpesvirus virions by disrupting formation of actin filament

Journal of Virology

Volumn 91, Issue 16, 2017, Pages

  Zou, Zhe ^a   Meng, Zhihua ^a   Ma, Chao ^c   Liang, Deguang ^d   Sun, Rui ^d   Lan, Ke ^b,d  

^a SHANGHAI UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

^c SHANGHAITECH UNIVERSITY   (China)

^d INSTITUTE PASTEUR OF SHANGHAI   (China)

Author keywords

Actin filaments; GBP1; GTPase activity; Kaposi's sarcomaassociated herpesvirus; KSHV; RTA

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATASE; GUANYLATE BINDING PROTEIN 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEASOME; UNCLASSIFIED DRUG; GBP1 PROTEIN, HUMAN; IMMEDIATE EARLY PROTEIN; RTA PROTEIN, HUMAN HERPESVIRUS 8; TRANSACTIVATOR PROTEIN;

ACTIN FILAMENT; ARTICLE; CELL DAMAGE; CELL NUCLEUS; CONTROLLED STUDY; DIMERIZATION; DISEASE COURSE; ENZYME ACTIVITY; HERPES VIRUS INFECTION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; INFECTION PREVENTION; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSCRIPTION INITIATION; VIRION; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS TRANSCRIPTION; CELL LINE; HOST PATHOGEN INTERACTION; IMMUNE EVASION; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; PROTEIN MULTIMERIZATION; TRANSPORT AT THE CELLULAR LEVEL;

ACTIN CYTOSKELETON; BIOLOGICAL TRANSPORT; CELL LINE; GTP-BINDING PROTEINS; HERPESVIRUS 8, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNE EVASION; PROTEIN MULTIMERIZATION; TRANS-ACTIVATORS; VIRION;

EID: 85026310020     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00632-17     Document Type: Article

References (47)

1. Giffin L, Damania B. 2014. KSHV: pathways to tumorigenesis and persistent infection. Adv Virus Res 88:111-159. https://doi.org/10.1016/B978-0-12-800098-4.00002-7
2. Mesri EA, Cesarman E, Boshoff C. 2010. Kaposi's sarcoma and its associated herpesvirus. Nat Rev Cancer 10:707-719. https://doi.org/10.1038/nrc2888
3. Ganem D. 2006. KSHV infection and the pathogenesis of Kaposi's sarcoma. Annu Rev Pathol Mech Dis 1:273-296. https://doi.org/10.1146/annurev.pathol.1.110304.100133
4. Ganem D. 2010. KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine. J Clin Invest 120:939-949. https://doi. org/10.1172/JCI40567
5. Naranatt PP, Krishnan HH, Smith MS, Chandran B. 2005. Kaposi's sarcoma-associated herpesvirus modulates microtubule dynamics via RhoA-GTP-diaphanous 2 signaling and utilizes the dynein motors to deliver its DNA to the nucleus. J Virol 79:1191-1206. https://doi.org/10. 1128/JVI.79.2.1191-1206.2005
6. Greene W, Gao SJ. 2009. Actin dynamics regulate multiple endosomal steps during Kaposi's sarcoma-associated herpesvirus entry and trafficking in endothelial cells. PLoS Pathog 5:e1000512. https://doi.org/10. 1371/journal.ppat.1000512
7. Raghu H, Sharma-Walia N, Veettil MV, Sadagopan S, Caballero A, Sivakumar R, Varga L, Bottero V, Chandran B. 2007. Lipid rafts of primary endothelial cells are essential for Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8-induced phosphatidylinositol 3-kinase and RhoA-GTPases critical for microtubule dynamics and nuclear delivery of viral DNA but dispensable for binding and entry. J Virol 81: 7941-7959. https://doi.org/10.1128/JVI.02848-06
8. Brulois K, Jung JU. 2014. Interplay between Kaposi's sarcoma-associated herpesvirus and the innate immune system. Cytokine Growth Factor Rev 25:597-609. https://doi.org/10.1016/j.cytogfr.2014.06.001
9. Bussey KA, Reimer E, Todt H, Denker B, Gallo A, Konrad A, Ottinger M, Adler H, Sturzl M, Brune W, Brinkmann MM. 2014. The gammaherpesviruses Kaposi's sarcoma-associated herpesvirus and murine gammaherpesvirus 68 modulate the Toll-like receptor-induced proinflammatory cytokine response. J Virol 88:9245-9259. https://doi.org/10.1128/JVI. 00841-14
10. Cai MS, Li ML, Zheng CF. 2012. Herpesviral infection and Toll-like receptor 2. Protein Cell 3:590-601. https://doi.org/10.1007/s13238-012-2059-9
11. Lee HR, Lee S, Chaudhary PM, Gill P, Jung JU. 2010. Immune evasion by Kaposi's sarcoma-associated herpesvirus. Future Microbiol 5:1349-1365. https://doi.org/10.2217/fmb.10.105
12. Sadagopan S, Sharma-Walia N, Veettil MV, Raghu H, Sivakumar R, Bottero V, Chandran B. 2007. Kaposi's sarcoma-associated herpesvirus induces sustained NF-kappaB activation during de novo infection of pri-mary human dermal microvascular endothelial cells that is essential for viral gene expression. J Virol 81:3949-3968. https://doi.org/10.1128/JVI. 02333-06
13. Kim BH, Shenoy AR, Kumar P, Bradfield CJ, MacMicking JD. 2012. IFNinducible GTPases in host cell defense. Cell Host Microbe 12:432-444. https://doi.org/10.1016/j.chom.2012.09.007
14. Martens S, Howard J. 2006. The interferon-inducible GTPases. Annu Rev Cell Dev Biol 22:559-589. https://doi.org/10.1146/annurev. cellbio.22.010305.104619
15. Prakash B, Praefcke GJ, Renault L, Wittinghofer A, Herrmann C. 2000. Structure of human guanylate-binding protein 1 representing a unique class of GTP-binding proteins. Nature 403:567-571. https://doi.org/10. 1038/35000617
16. Naschberger E, Werner T, Vicente AB, Guenzi E, Popolt K, Leubert R, Lubeseder-Martellato C, Nelson PJ, Sturzl M. 2004. Nuclear factor-κB motif and interferon-α-stimulated response element co-operate in the activation of guanylate-binding protein-1 expression by inflammatory cytokines in endothelial cells. Biochem J 379:409-420. https://doi.org/10.1042/bj20031873
17. Chappie JS, Acharya S, Leonard M, Schmid SL, Dyda F. 2010. G domain dimerization controls dynamin's assembly-stimulated GTPase activity. Nature 465:435-440. https://doi.org/10.1038/nature09032
18. Vestal DJ. 2005. The guanylate-binding proteins (GBPs): proinflammatory cytokine-induced members of the dynamin superfamily with unique GTPase activity. J Interferon Cytokine Res 25:435-443. https://doi.org/10.1089/jir.2005.25.435
19. Itsui Y, Sakamoto N, Kakinuma S, Nakagawa M, Sekine-Osajima Y, Tasaka-Fujita M, Nishimura-Sakurai Y, Suda G, Karakama Y, Mishima K, Yamamoto M, Watanabe T, Ueyama M, Funaoka Y, Azuma S, Watanabe M. 2009. Antiviral effects of the interferon-induced protein guanylate binding protein 1 and its interaction with the hepatitis C virus NS5B protein. Hepatology 50:1727-1737. https://doi.org/10.1002/hep.23195
20. Zhu Z, Shi Z, Yan W, Wei J, Shao D, Deng X, Wang S, Li B, Tong G, Ma Z. 2013 Nonstructural protein 1 of influenza A virus interacts with human guanylate-binding protein 1 to antagonize antiviral activity. PLoS One 8:e55920. https://doi.org/10.1371/journal.pone.0055920
21. Pan W, Zuo X, Feng T, Shi X, Dai J. 2012. Guanylate-binding protein 1 participates in cellular antiviral response to dengue virus. Virol J 9:292. https://doi.org/10.1186/1743-422X-9-292
22. Grossmann C, Ganem D. 2008. Effects of NFkappaB activation on KSHV latency and lytic reactivation are complex and context-dependent. Virology 375:94-102. https://doi.org/10.1016/j.virol.2007.12.044
23. Anderson SL, Carton JM, Lou J, Xing L, Rubin BY. 1999. Interferoninduced guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and encephalomyocarditis virus. Virology 256:8-14. https://doi.org/10.1006/viro.1999.9614
24. Li LF, Yu J, Li Y, Wang J, Li S, Zhang L, Xia SL, Yang Q, Wang X, Yu S, Luo Y, Sun Y, Zhu Y, Munir M, Qiu HJ. 2016. Guanylate-binding protein 1, an interferon-induced GTPase, exerts an antiviral activity against classical swine fever virus depending on its GTPase activity. J Virol 90:4412-4426. https://doi.org/10.1128/JVI.02718-15
25. Kim BH, Shenoy AR, Kumar P, Das R, Tiwari S, MacMicking JD. 2011. A family of IFN-γ-inducible 65-kD GTPases protects against bacterial infection. Science 332:717-721. https://doi.org/10.1126/science.1201711
26. Zhao Q, Liang D, Sun R, Jia B, Xia T, Xiao H, Lan K. 2015. Kaposi's sarcoma-associated herpesvirus-encoded replication and transcription activator impairs innate immunity via ubiquitin-mediated degradation of myeloid differentiation factor 88. J Virol 89:415-427. https://doi.org/10.1128/JVI.02591-14
27. Jarviluoma A, Ojala PM. 2006. Cell signaling pathways engaged by KSHV. Biochim Biophys Acta 1766:140-158
28. Yu Y, Wang SE, Hayward GS. 2005. The KSHV immediate-early transcription factor RTA encodes ubiquitin E3 ligase activity that targets IRF7 for proteosome-mediated degradation. Immunity 22:59-70. https://doi.org/10.1016/j.immuni.2004.11.011
29. Ishido S, Wang C, Lee BS, Cohen GB, Jung JU. 2000. Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcomaassociated herpesvirus K3 and K5 proteins. J Virol 74:5300-5309. https://doi.org/10.1128/JVI.74.11.5300-5309.2000
30. Coscoy L, Ganem D. 2000. Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proc Natl Acad Sci U S A 97:8051-8056. https://doi.org/10.1073/pnas.140129797
31. West J, Damania B. 2008. Upregulation of the TLR3 pathway by Kaposi's sarcoma-associated herpesvirus during primary infection. J Virol 82: 5440-5449. https://doi.org/10.1128/JVI.02590-07
32. Matta H, Chaudhary PM. 2004. Activation of alternative NF-kappa B pathway by human herpes virus 8-encoded Fas-associated death domain-like IL-1 beta-converting enzyme inhibitory protein (vFLIP). Proc Natl Acad Sci U S A 101:9399-9404. https://doi.org/10.1073/pnas.0308016101
33. Myoung J, Ganem D. 2011. Generation of a doxycycline-inducible KSHV producer cell line of endothelial origin: maintenance of tight latency with efficient reactivation upon induction. J Virol Methods 174:12-21. https://doi.org/10.1016/j.jviromet.2011.03.012
34. Gerrit JK, Praefcke CH. 1999. Nucleotide-binding characteristics of human guanylate-binding protein 1 (hGBP1) and identification of third GTP-binding motif. J Mol Biol 292:321-332
35. Vetter IR, Wittinghofer A. 2001. The guanine nucleotide-binding switch in three dimensions. Science 294:1299-1304. https://doi.org/10.1126/science.1062023
36. Praefcke GJ, Kloep S, Benscheid U, Lilie H, Prakash B, Herrmann C. 2004. Identification of residues in the human guanylate-binding protein 1 critical for nucleotide binding and cooperative GTP hydrolysis. J Mol Biol 344:257-269. https://doi.org/10.1016/j.jmb.2004.09.026
37. Wehner M, Kunzelmann S, Herrmann C. 2012. The guanine cap of human guanylate-binding protein 1 is responsible for dimerization and self-activation of GTP hydrolysis. FEBS J 279:203-210. https://doi. org/10.1111/j.1742-4658.2011.08415.x
38. Modiano N, Lu YE, Cresswell P. 2005. Golgi targeting of human guanylate-binding protein-1 requires nucleotide binding, isoprenylation, and an IFN-gamma-inducible cofactor. Proc Natl Acad Sci U S A 102: 8680-8685. https://doi.org/10.1073/pnas.0503227102
39. Britzen-Laurent N, Bauer M, Berton V, Fischer N, Syguda A, Reipschlager S, Naschberger E, Herrmann C, Sturzl M. 2010. Intracellular trafficking of guanylate-binding proteins is regulated by heterodimerization in a hierarchical manner. PLoS One 5:e14246. https://doi.org/10.1371/journal. pone.0014246
40. Ostler N, Britzen-Laurent N, Liebl A, Naschberger E, Lochnit G, Ostler M, Forster F, Kunzelmann P, Ince S, Supper V, Praefcke GJ, Schubert DW, Stockinger H, Herrmann C, Sturzl M. 2014. Gamma interferon-induced guanylate binding protein 1 is a novel actin cytoskeleton remodeling factor. Mol Cell Biol 34:196-209. https://doi.org/10.1128/MCB.00664-13
41. Cheng F, He M, Jung JU, Lu C, Gao SJ. 2016. Suppression of Kaposi's sarcoma-associated herpesvirus infection and replication by 5=-AMPactivated protein kinase. J Virol 90:6515-6525. https://doi.org/10.1128/JVI.00624-16
42. Bechtel JT, Winant RC, Ganem D. 2005. Host and viral proteins in the virion of Kaposi's sarcoma-associated herpesvirus. J Virol 79:4952-4964. https://doi.org/10.1128/JVI.79.8.4952-4964.2005
43. Lan K, Kuppers DA, Verma SC, Sharma N, Murakami M, Robertson ES. 2005 Induction of Kaposi's sarcoma-associated herpesvirus latencyassociated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency. J Virol 79:7453-7465. https://doi.org/10.1128/JVI.79.12.7453-7465.2005
44. Andreoli M, Persico M, Kumar A, Orteca N, Kumar V, Pepe A, Mahalingam S, Alegria AE, Petrella L, Sevciunaite L, Camperchioli A, Mariani M, Di Dato A, Novellino E, Scambia G, Malhotra SV, Ferlini C, Fattorusso C. 2014. Identification of the first inhibitor of the GBP1:PIM1 interaction. Implications for the development of a new class of anticancer agents against paclitaxel resistant cancer cells. J Med Chem 57:7916-7932. https://doi.org/10.1021/jm5009902
45. Lan K, Kuppers DA, Verma SC, Robertson ES. 2004. Kaposi's sarcomaassociated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency. J Virol 78:6585-6594. https://doi.org/10.1128/JVI.78.12.6585-6594.2004
46. Pozharskaya VP, Weakland LL, Offermann MK. 2004. Inhibition of infectious human herpesvirus 8 production by gamma interferon and alpha interferon in BCBL-1 cells. J Gen Virol 85:2779-2787. https://doi.org/10. 1099/vir.0.80214-0
47. Konrad A, Wies E, Thurau M, Marquardt G, Naschberger E, Hentschel S, Jochmann R, Schulz TF, Erfle H, Brors B, Lausen B, Neipel F, Sturzl M. 2009 A systems biology approach to identify the combination effects of human herpesvirus 8 genes on NF-kappaB activation. J Virol 83: 2563-2574. https://doi.org/10.1128/JVI.01512-08